NEW YORK, NY – Two prominent biotechnology companies, Vertex Pharmaceuticals and CRISPR Therapeutics, both led by Indian American CEOs, have been named to TIME’s 2025 list of the 100 Most Influential ...

Following an orchestrated "Admin War" between two of the most popular games in the platform's history, Roblox managed to hit a record-breaking 47.4 million concurrent players, making it the most-used ...

Results may also be viewed at http://www.aspencyclingclub.org. Questions about results should be directed to results@aspencyclingclub.org.

Drew Dirksen tries parkour for the first time while wearing Crocs in a daring new video. New players may have window to disrupt after trucks exit California emissions deals Man repairing home uncovers ...

While players will spend most of their time in Drag x Drive on the court, they will surely explore the park at some point and see what other activities the game has to offer. They will quickly notice ...

Roblox has long-term potential -- but the path is expensive. Roblox's valuation assumes near-flawless execution. Investors need conviction in the long game. But while the story is compelling, the ...

American cyclist Brandon McNulty has won the Tour de Pologne after winning Sunday’s climactic time trial. The 27-year-old had been second entering the stage, seven seconds behind INEOS Grenadiers’ ...

I went on an eight-hour drive with my dad yesterday. And I was a bit too enthusiastic going over my local mountain pass. He asked if I wanted to kill him, as the sound of the tires squeaking increased ...

We recently published 10 Big Names Bleed Double Digits. Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) is one of the worst-performing stocks on Tuesday. Vertex Pharmaceuticals nosedived on Tuesday to hit a ...

Vertex reported healthy revenue in its second quarter earnings report, though news of VX-993’s mid-stage trial results and lack of alignment with the FDA regarding an expanded label for Journavx ...

Aug 4 (Reuters) - Vertex Pharmaceuticals will stop developing its experimental non-opioid painkiller as a solo treatment after a mid-stage trial failure and will not start a study for expanded use of ...